Study

Rejected
Manoel et al., 2018
Beta-blockers in Traumatic Brain Injury
[10.5005/jp-journals-10030-1241]

Description

Rejected: not a Drosophila study. Clinical review of beta-blocker treatment after traumatic brain injury in human patients; it has no DGRP data.

Comments from curator

No phenotype data: this study was rejected because it is not a Drosophila study.

This article is a clinical review on human patients. It describes the surge of catecholamines after traumatic brain injury (TBI), its links with cardiac, pulmonary, coagulation and inflammatory complications and with outcome, and the clinical trials, observational studies and meta-analyses that associate beta-blocker treatment with lower mortality and better functional outcome after TBI. It reports no experiment of its own, uses no DGRP line and does not mention Drosophila.

The DGRP study on the same subject is Scharenbrock et al., 2021, microPublication Biology (PMC version). It measured early mortality (MI24) and intestinal permeability (SI24) after traumatic brain injury in 18 DGRP lines fed the beta-blockers labetalol or metoprolol. Its per-line values are only shown in a figure. This record was probably meant for that paper.

categories

None

No phenotype

No data

DGRP lines

None

Datasets

Back to studies